PRESENT AND FUTURE

Clinical pathways, today and on the horizon.

Three indications with preventive, longevity and family health intelligence on the roadmap.

SOON

Phase 1.

Three indications where regular immune monitoring can support earlier intervention.

Acute care

Decentralised pathways that move monitoring out of the ward and into the home.

Oncology

Optimisation of chemotherapy cycles and early detection of febrile neutropenia risk preventing high-cost admissions.

Psychiatry

Support monitoring for haematological surveillance.

Community care

At community nursing and care homes, supporting earlier identification of deterioration.

On the roadmap

Preventive health, chronic disease, longevity, family health intelligence and home healthcare programmes on our roadmap.

Future

See the full roadmap of programmes in development across preventive, longevity and family health.

Book a 20-minute briefing with our team to see Algocyte in action.